A. Vibert et al. / Tetrahedron Letters 51 (2010) 1867–1869
1869
applied to complex molecules such as CS oligomers. Classical
reduction conditions10 were tested on several chondroitin oligo-
saccharides which have been used as key intermediates during
CS oligomer syntheses.4a–c,11 These molecules are equipped with
different protective groups at the anomeric center, and bear di-
verse ester (acetate, benzoate, and levulinate) or hydroxy groups
on the other positions (Scheme 1).
The results of these studies are reported in Table 1. The reduc-
tion reaction was first attempted on peracetylated disaccharide
derivative 1 (entry 1). The reaction proceeded smoothly and was
complete within 24 h at 50 °C giving the acetamide 8 in 95% yield.
Next were tested glycosides 2 and 3 (entries 2 and 3), which differ
only by the chirality at the anomeric center with a bulky 2-naph-
thylmethyl group in the vicinity of the trichloroacetyl group. Both
reductions proceeded well and the acetamides 9 and 10, respec-
tively, were isolated in good yields. More interesting is the reduc-
tion of 4 (entry 4) which possesses a benzyl carbamate and a free
hydroxy group. In that case, neither cleavage of the carbamate nor
acetylation of the hydroxyl was observed. When these conditions
were applied to disaccharide derivative 5 (entry 5) having a free
thetic intermediates bearing
group in the synthesis of other members of the biologically rele-
vant GAG’s family such as hyaluronic acid and dermatan sulfate.
a
2-deoxy-2-trichloroacetamido
Acknowledgments
This research was supported by the Program ANR-08-PCVI-
0023-02 ‘GAGNetwork’. We are grateful for the support by the
Ministère de l’Enseignement Supérieur et de la Recherche through
a studentship to A.V.
Supplementary data
Supplementary data (Protocols for each reaction and 1H and 13
NMR data for reduced products) associated with this article can be
C
References and notes
1. Iozzo, R. V. Annu. Rev. Biochem. 1998, 67, 609–652.
2. Lemieux, R. U.; Ratcliffe, R. M. Can. J. Chem. 1979, 57, 1244–1251.
3. (a) Tamura, J.-I.; Nakada, Y.; Tanigushi, K.; Yamane, M. Carbohydr. Res. 2008,
343, 39–47; (b) Tamura, J.-I.; Tokuyoshi, M. Biocsci. Biotechnol. Biochem. 2004,
68, 2436–2443; (c) Tamura, J.-I.; Neumann, K. W.; Ogawa, T. Bioorg. Med. Chem.
Lett. 1995, 5, 1351–1354; (d) Tamura, J. I.; Neumann, K. W.; Kurov, S.; Ogawa, T.
Carbohydr. Res. 1998, 305, 43–63.
4. (a) Vibert, A.; Lopin-Bon, C.; Jacquinet, J.-C. Chem. Eur. J. 2009, 15, 9561–9578;
(b) Jacquinet, J.-C.; Lopin-Bon, C.; Vibert, A. Chem. Eur. J. 2009, 15, 9579–9595;
(c) Lopin, C.; Jacquinet, J.-C. Angew. Chem., Int. Ed. 2006, 45, 2574–2578; (d)
Karst, N.; Jacquinet, J.-C. Eur. J. Org. Chem. 2002, 815–825; (e) Bélot, F.;
Jacquinet, J.-C. Carbohydr. Res. 2000, 326, 88–97.
5. (a) Coutant, C.; Jacquinet, J.-C. J. Chem. Soc., Perkin Trans. 1 1995, 1573–1581; (b)
Blatter, G.; Beau, J.-M.; Jacquinet, J.-C. Carbohydr. Res. 1994, 260, 189–202.
6. El-Abadla, N.; Lampilas, M.; Henning, L.; Findeisen, M.; Welzel, P.; Müller, D.;
Markus, A.; van Heijenoort, J. Tetrahedron 1999, 55, 699–722.
7. Barker, J.; Müller, R.; Kosma, P. Carbohydr. Res. 1998, 308, 259–273.
8. Dinkelaar, J.; Gold, H.; Overkleft, H. S.; Codee, J. D. C.; van der Marel, G. A. J. Org.
Chem. 2007, 72, 5737–5742.
9. (a) Ueki, A.; Nakahara, Y.; Hojo, H.; Nakahara, Y. Tetrahedron 2007, 63, 2170–
2181; (b) Hanashima, S.; Castagner, B.; Esposito, D.; Nokami, T.; Seeberger, P. H.
Org. Lett. 2007, 9, 1777–1779; (c) Takano, Y.; Kojima, N.; Nakahara, Y.; Hojo, H.;
Nakahara, Y. Tetrahedron 2003, 59, 8415–8427; (d) Ichikawa, Y. Chem. Lett.
1990, 1347–1350.
10. General procedure for the reduction reaction: Zn–Cu couple (Acros Organics,
100 mg, 1.5 mmol) was added portionwise to a solution of the starting material
(0.1 mmol) in pure acetic acid (1.5 mL) at 50 °C under Ar, and the mixture was
stirred for the allotted time (see Table 1), cooled, filtered through a pad of
CeliteÒ, and concentrated. The resulting residues were directly purified by
flash-silica chromatography.
hydroxyl group at C-4 of the D-galactosamine unit, a mixture of
products was obtained in which the desired acetamide 12 could
be isolated in only 48% yield. A major side-product was formed
and unambiguously identified through 1H and 13C NMR as the
furanoside 15.12 Such a modification of structure resulting from
ring contraction at the D-galactosamine unit was already observed
on the parent molecules under acidic conditions.4d We assumed
that the zinc salts slowly released during the reaction acted as a Le-
wis acid which led to transient open-chain oxonium ion which re-
acted further with the free 4-OH group to provide the furanoside
15. However, shortening the reaction time to 5 h allowed the isola-
tion of acetamide 12 in an improved 71% yield. Starting from disac-
charide 6 having a free hydroxy group at C-6 and a benzoate ester
at C-4, no side-product was formed, and acetamide 13 was isolated
in 85% yield. Both compounds 12 and 13 were now ready for sub-
sequent O-sulfonation. More relevant is the reduction of tetrasac-
charide 7 (entry 7) bearing two trichloroacetyl groups, which
gave diacetamide 14 in 93% yield, whereas the radical-mediated
reductive dehalogenation allowed the isolation of 14 in only 62%
yield. As a general rule, the yields of the reactions are 20–30% supe-
rior to those obtained by the tin procedure.
In conclusion, these mild conditions using an operationally sim-
ple procedure worked well on a large panel of chondroitin deriva-
tives with one or more trichloroacetyl group(s) and compared well
with those previously reported,5 and could be applied to other syn-
11. Vibert, A. PhD Thesis, University of Orléans (France), November 2009.
12. See Supplementary data.